Global Pharmaceutical Membrane Filtration Market Size Likely to Surpass at a CAGR of 13.4% By 2033

As per the current market research conducted by the CMI Team, the global Pharmaceutical Membrane Filtration Market size is expected to record a CAGR of 13.4% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 11,450 Million. By 2033, the valuation is anticipated to reach USD 27,620 Million.

Pharmaceutical Membrane Filtration Market: Growth Factors and Dynamics

• Increasing Pharmaceutical Production: The growing demand for pharmaceutical products, such as vaccines, biologics, and biosimilars, increases the need for efficient filtering methods to maintain product purity and safety.

• Technological Advancements: Innovations in membrane filtration technologies, such as the development of new materials and procedures, improve the efficiency, selectivity, and durability of filtration membranes, resulting in market expansion.

• Stringent Regulatory Standards: Regulatory authorities such as the FDA and EMA set tight restrictions for medication production processes, including filtration requirements. Compliance with these standards needs improved filtering solutions, which drives market demand.

• Growth of Biopharmaceuticals: The growing emphasis on biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and cell treatments, need specialized filtration processes to handle complex biological products.

• Water and Wastewater Treatment: In the pharmaceutical industry, water used in production must meet high purity standards. The need for effective water and wastewater treatment systems, which often rely on membrane filtration, supports market growth.

• Expansion in Developing Regions: Growing pharmaceutical manufacturing capabilities in developing regions like Asia-Pacific, Latin America, and Africa drive the demand for advanced filtration technologies to ensure high-quality production.

• Rising Incidences of Chronic Diseases: The global growth in chronic diseases such as diabetes, cancer, and cardiovascular diseases raises the need for pharmaceuticals, hence increasing the need for membrane filtration in drug manufacturing.

• Environmental Concerns and Sustainability: The pharmaceutical industry’s focus on reducing its environmental footprint promotes the adoption of membrane filtration systems that offer efficient and sustainable solutions for waste management and resource recovery.

Pharmaceutical Membrane Filtration Market: Facility expansion and product launch

• In October 2023, Cytiva (US) announced the opening of a 33,000 ft2 manufacturing plant in Pune, India. The new plant will produce bioprocessing equipment including tangential flow, viral filtering, and inactivation systems.

• In March 2023, Parker Hannifin, a motion and control technology company, established a new Bioscience Filtration plant in Birtley, United Kingdom. This facility was established to increase the company’s manufacturing capacity and meet the growing demand from the pharmaceutical, biopharmaceutical, and food and beverage industries.

• In May 2022, Merck, a scientific and technology company, announced a new development of membrane and filtering production capabilities in Ireland. The business has invested $481.26 billion to expand its membrane manufacturing capacity in Carrigtwohill and open a new manufacturing plant at Blarney Business Park, both in Cork, Ireland.

• In November 2023, Repligen Corporation (US) introduced a holder-free, self-contained tangential flow filtration (TFF) device to develop downstream flat sheet TFF technology for ultrafiltration and diafiltration (UF/DF).

• In December 2023, TeraPore Technologies, a company that specialises in nanofiltration membranes, created the IsoBlock VF product line, which is specifically designed to remove parvovirus from pharmaceuticals.

Report Scope

Pharmaceutical Membrane Filtration Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Pharmaceutical Membrane Filtration Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Supply Chain Disruptions: The pandemic developed severe disruptions in worldwide supply chains, reducing the availability of raw materials and components used to manufacture membrane filtration products. This resulted in delays and higher costs.

• Operational Challenges: Lockdowns, social distancing measures, and shortages of workers all created operational issues for manufacturers. These problems occasionally resulted in lower manufacturing capacity and efficiency.

• Economic Uncertainty: The economic downturn caused by the pandemic led to budget constraints and reduced spending in some sectors. While the pharmaceutical industry saw growth, other industries that use membrane filtration experienced contractions, impacting overall market dynamics.

• Regulatory Hurdles: The rapid pace of vaccine and drug development introduced new regulatory challenges. Companies had to navigate evolving guidelines and ensure compliance, which sometimes slowed down the adoption of new filtration technologies.

• Increased Demand for Filtration Products: The pandemic has driven a surge in the production of vaccines, drugs, and other medical supplies, leading to heightened demand for membrane filtration technologies used in the purification and sterilization processes.

• Technological Advancements: The urgent need for efficient and scalable production of medical treatments has accelerated innovation and the adoption of advanced filtration technologies. This includes the development of more efficient membranes and filtration systems that enhance productivity and ensure higher purity levels.

• Government and Private Sector Investments: Increased funding and support from governments and private entities for pharmaceutical research and production have bolstered the market. Investments in building and upgrading manufacturing facilities have expanded the market for membrane filtration products.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Pharmaceutical Membrane Filtration Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Pharmaceutical Membrane Filtration Market:

• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• 3M Company
• Parker Hannifin Corporation
• Repligen Corporation
• Asahi Kasei Corporation
• Eaton Corporation plc
• GEA Group
• Corning Incorporated
• Alfa Laval Corporate AB
• Donaldson Company Inc.
• Saint-Gobain
• MANN+HUMMEL International GmbH & Co. KG
• Meissner Filtration Products Inc.
• Cole-Parmer Instrument Company LLC
• Cantel Medical Corp.
• L. Gore & Associates Inc
• Others

The Pharmaceutical Membrane Filtration Market is segmented as follows:

By Product

• Membrane Filters
• Systems
• Other Products

By Technique

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other Techniques

By Application

• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

By Type

• Sterile Filtration
• Non-Sterile Filtration

By Scale of Operation

• Manufacturing-Scale Operation
• Pilot-Scale Operation
• R&D-Scale Operation

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America